XW133SBTransfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11
- Billable / Specific Code
- New for FY 2026
XW133SB is a billable ICD-10-PCS procedure code for Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRGs 016, 017. The root operation Transfusion involves putting in blood or blood products.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | W | Anatomical Regions |
| 3 | Operation | 1 | Transfusion |
| 4 | BodyPart | 3 | Peripheral Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | S | Mozafancogene Autotemcel |
| 7 | Qualifier | B | New Technology Group 11 |
Code History
- 30233C0 — Transfuse Autol HSPC, Gene Mod in Periph Vein, Perc
Similar Procedure Codes
Questions About XW133SB
Is XW133SB a billable code?
Yes. XW133SB is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XW133SB mean?
XW133SB breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 1 is the Operation (Transfusion); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character S is the Device/Substance/Technology (Mozafancogene Autotemcel); the 7th character B is the Qualifier (New Technology Group 11).
What MS-DRG does XW133SB group to?
On an inpatient stay, Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11 maps to MS-DRGs 016, 017, with relative weights from 4.8383 to 5.9297. The MS-DRG sets the fixed Medicare payment for the stay.
